Long-term results of gamma knife surgery for growth hormone producing pituitary adenoma: is the disease difficult to cure?
|
|
- Dayna Short
- 5 years ago
- Views:
Transcription
1 J Neurosurg (Suppl) 102: , 2005 Long-term results of gamma knife surgery for growth hormone producing pituitary adenoma: is the disease difficult to cure? TATSUYA KOBAYASHI, M.D., PH.D., YOSHIMASA MORI, M.D., PH.D., YUKIO UCHIYAMA, M.P., M.SC., YOSHIHISA KIDA, M.D., PH.D., AND SHIGERU FUJITANI, M.D. Radiosurgery Center, Nagoya Kyoritsu Hospital and Gamma Knife Center, Komaki City Hospital, Nagoya, Japan Object. The authors conducted a study to determine the long-term results of gamma knife surgery for residual or recurrent growth hormine (GH) producing pituitary adenomas and to compare the results with those after treatment of other pituitary adenomas. Methods. The series consisted of 67 patients. The mean tumor diameter was 19.2 mm and volume was 5.4 cm 3. The mean maximum dose was 35.3 Gy and the mean margin dose was 18.9 Gy. The mean follow-up duration was 63.3 months (range months). The tumor resolution rate was 2%, the response rate 68.3%, and the control rate 100%. Growth hormone normalization (GH 1.0 ng/ml) was found in 4.8%, nearly normal ( 2.0 ng/ml) in 11.9%, significantly decreased ( 5.0 ng/ml) in 23.8%, decreased in 21.4%, unchanged in 21.4%, and increased in 16.7%. Serum insulin-like growth factor (IGF) 1 was significantly decreased (IGF ng/ml) in 40.7%, decreased in 29.6%, unchanged in 18.5%, and increased in 11.1%, which was almost parallel to the GH changes. Conclusions. Gamma knife surgery was effective and safe for the control of tumors; however, normalization of GH and IGF-1 secretion was difficult to achieve in cases with large tumors and low-dose radiation. Gamma knife radiosurgery is thus indicated for small tumors after surgery or medication therapy when a relatively high-dose radiation is required. KEY WORDS gamma knife surgery growth hormone producing pituitary adenoma insulin-like growth factor S TANDARDIZED treatments for pituitary adenomas have long relied on a combination of resection, pharmacotherapy, and radiation therapy. 3,12,16 This strategy has also been applied to GH-producing adenomas. Fractionated radiation therapy 2,6,15 has been used to control tumor growth and GH production. Significant control has been achieved with these treatments; however, realization of the desired effects 2,6,16 takes a long time to achieve and the side effects of radiation therapy are potentially serious. Hypothalamic pituitary hypofunction is the most common adverse effect, 3,12,16 and this is followed by deterioration of visual function and mental (especially memory) disturbances. 12 The mortality rate observed in acromegalic patients with uncontrolled hormone secretion is also high. 1,3 Stereotactic radiosurgery has also been undertaken in the treatment of pituitary adenomas. Gamma knife surgery based on high-resolution MR imaging has made selective irradiation of pituitary adenomas possible without significant side effects. 4,7,9,11,13,14,17 19 The purpose of this study was Abbreviations used in this paper: GH = growth hormone; GKS = gamma knife surgery; IGF = insulin-like growth factor; MR = magnetic resonance. to determine the effectiveness of GKS for GH-producing adenomas in patients with relatively long-term follow up (mean follow-up period 5 years). The results are compared with those results of GKS for other types of pituitary adenoma. Clinical Material and Methods Of 267 GKS-treated pituitary adenoma cases since 1991, 136 were functioning adenomas. Of these cases, 71 were acromegaly, 33 were prolactinomas, and 32 had Cushing disease. In this study, 67 of 71 acromegaly cases underwent follow-up examinations for more than 1 year. The mean age was 47 years (range years) and the male/female ratio was 23:44. Treatments prior to GKS consisted of resection in 49 cases, medication therapy in 42, and conventional radiation therapy in two. In nine cases GKS was the initial treatment. The mean tumor diameter was 19.2 mm (range mm). The mean volume was 5.4 cm 3. Residual or recurrent tumors were treated with GKS in which the mean maximum dose was 35.3 Gy and the mean margin dose was 18.9 Gy (Table 1). 119
2 T. Kobayashi, et al. TABLE 1 Characteristics and dose planning in 67 patients with GH-producing pituitary adenoma Parameter Results Value follow up 63.3 mos age (yrs) mean 47 range M/F ratio 23:45 pre-gks treatment no.s op 49 no op 9 medical 42 radiation therapy 2 mean size diameter 19.2 mm vol 4.4 cm 3 size distribution microadenoma (diameter 1 cm) 3 small (diameter 2 cm) 41 macroadenoma (diameter 3 cm) 23 huge adenoma (diameter 3 cm) 3 mean maximum dose (Gy) 35.3 mean margin dose (Gy) 18.9 mean no. isocenters 4.23 The mean follow-up period was 63.3 months (range months) and changes in tumor size were evaluated by MR imaging every 3 to 6 months in 49 cases. The tumor showed complete remission in one case, partial remission in 31, and no change in 17. None showed progression of tumor as outlined in Table 2. The serum GH level was tested preand posttreatment in 42 cases. The level dropped below 1 ng/ml (normal) in two cases (4.8%), below 2 ng/ml in five (11.9%), below 5 ng/ml in 10 (23.8%), decreased but still exceeded 50% of the preoperative level in nine (21.4%), was unchanged in nine (21.4%), and increased in seven (16.7%). These changes are specified in Table 3. Serum IGF-1 levels were determined in 27 cases. Serum IGF-1 dropped below 400 ng/ml in 11 cases (40.7%), and the changes essentially ran in parallel with those in GH levels as shown in Table 4. The clinical outcome and side effects were determined by assessing clinical records and/or by questionnaire. Vision was improved or unchanged in 26.6%, deteriorated in 11.1%, and showed no deficit in 62.3%. Hypopituitarism TABLE 2 Tumor changes after GKS in 49 patients* Characteristic Value (%) mean 32.2 range 6 96 CR (disappeared) 1 (2) PR ( 25% decreased) 31 (66.3) NC 17 (34.7) PG (enlarged) 0 total 49 (100) * CR = complete response; NC = no change; PG = progression; PR = partial remission. CR = 2.0%; response rate = CR PR (68.3%); and control rate = CR PR NC (100%). was improved or unchanged in 39.0%, deteriorated in 14.6%, and showed no deficit in 46.3% as shown in Table 5. Three patients died, and only in one death was due to a pituitary cause, namely hypopituitarism. According to questionnaire results, 24 (66.7%) were satisfied with radiosurgery, 10 (27.8%) were dissatisfied, and two (5.5%) did not respond. Dissatisfaction was generally attributed a persistently pathological GH level or to a lack of change in symptoms or to MR imaging findings. Case 1 Case Illustrations This 26-year-old woman had a residual microadenoma (10.8 mm in diameter and 0.66 cm 3 in volume) with increased GH and IGF-1 levels (1.66 and 590 ng/ml, respectively) after undergoing transsphenoidal surgery. The tumor was treated with a margin dose of 25 Gy. The tumor shrank and serum hormone levels had normalized (GH 0.8; IGF ng/ml) 7 years after treatment as illustrated in Fig. 1. Case 2 TABLE 3 Growth hormone changes after GKS in 42 patients Parameter Value (%) mean 36 range normalized (GH 1.0 ng/ml) 2 (4.8) nearly normal (GH <2.0 ng/ml) 5 (11.9) significant decrease (GH 5.0 ng/ml) 10 (23.8) decreased ( 50%) 9 (21.4) no change ( 50% decreased or unchanged) 9 (21.4) increased 7 (16.7) total 42 (100) This 46-year-old woman had an intrasellar macroadenoma with a mean diameter of 23.1 mm. The lesion was treat- TABLE 4 Changes in IGF-1 after GKS in 27 patients Parameter Value (%) mean 32.5 range 6 85 significant decrease 11 (40.7) decreased 8 (29.6) no change 5 (18.5) increased (3 (11.1) total 27 (100) TABLE 5 Effects and side effects of GKS in 47 of 67 patients Parameter Result (%) Deteriorated Improved No Change No Deficits visual (Va,VF) (15 cases) 5 (11.1) 2 (4.4) 10 (22.2) 28 (62.3) endocrine 6 (14.6) 4 (9.7) 12 (29.3) 19 (46.3) nausea, headache (41 cases) 2 (4.9) 1 (2.4) 7 (17.1) 31 (75.6) 120
3 Gamma knife surgery for GH-producing pituitary adenoma FIG. 1. Effect of GKS for GH-producing microadenoma. A residual microadenoma (10.8 mm) after transsphenoidal surgery was treated with a marginal dose of 25 Gy. The tumor had disappeared (complete response) and the GH level had normalized 30 months after treatment. ed with a margin dose of 16 Gy because medical treatment had been ineffective. The tumor gradually decreased in size and had disappeared at 97 months. The GH and IGF-1 levels also significantly decreased (7.76 and 290 ng/ml, respectively) as illustrated in Fig. 2. Case 3 This 57-year-old woman had a very large adenoma, with suprasellar extension, which was initially treated by intracranial surgery for debulking of the tumor mass and optic nerve decompression. The 32.9-mm-diameter and 18.7-cm 3 tumor was treated with a margin dose of 12 Gy. The tumor showed a partial remission at 36 months after treatment. A second GKS was administered with the goal of reducing tumor size (now 27 mm in diameter and 10.3 cm 3 in volume). A margin dose of 14 Gy was used. The tumor showed a further size reduction, and hormone levels decreased at 8 years after the initial treatment as shown in Fig. 3. Discussion Selective tumor irradiation became possible in the early 1990 when MR imaging was introduced into dose planning. In 1991, Thoren, et al., 17 reported results after using 40- to 70-Gy GKS in 21 cases and found that two had been cured and that improvement of symptoms and a significant decreased GH levels were obtained in eight. Ganz, et al., 4 reported four cases treated with a mean marginal dose of 19.9 Gy. Hormone levels decreased in all four but only one case was considered cured. Witt, et al., 18 reported 29 cases treated with a mean marginal dose of 19.2 Gy. Normalization of GH was obtained in 72% but IGF-1 normalized in only 27%. Landolt, et al., 11 treated 16 cases of refractory acromegaly with a mean marginal dose of 25 Gy and compared the results with those obtained in 50 patients who underwent fractionated radiotherapy. Gamma knife surgery resulted in normalization of both GH and IGF-1 levels within a mean period of 1.4 years in 50% of cases, whereas normalization was not seen until 7.1 years after fractionated radiotherapy. Normalization was not achieved in three cases in which doses lower than 25 Gy were used. There was no correlation between tumor volume reduction and hormone level normalization. The major side effect of conventional radiotherapy was hypopituitarism, which developed in eight FIG. 2. Effect of GKS for intrasellar macroadenoma. An intrasellar macroadenoma (23.1 mm), refractory to medical treatments, was irradiated with a marginal dose of 16 Gy. The tumor disappeared (complete response) almost entirely, and the GH and IGF-1 levels were significantly decreased at 97 months after treatment. 121
4 T. Kobayashi, et al. FIG. 3. Effect of GKS for huge adenoma with suprasellar extension. After surgically debulking the tumor and decompressing the optic nerves, the tumor was irradiated with a marginal dose of 12 Gy. The tumor showed partial response but the GH secretion was not controlled at 37 months. A second GKS treatment, with a marginal dose of 14 Gy, was administered. The tumor further decreased in size but without effect on GH secretion cases (16%), in five of which hormone replacement was required. In one case with a progressive 19-month history of hypothalamic disturbance the patient ultimately became blind. There were no side effects in the GKS-treated group. The authors later pointed out the possibility that drugs such as octreotide might reduce the efficacy of radiation therapy. 10 Zhang, et al., 19 reported the results of initial GKS treatment for 68 acromegaly cases. The tumors, with a mean diameter of 13 mm, were treated with a mean marginal dose of 31.3 Gy. The GH levels normalized in 96% and the tumor volume reduced in 92%, during a mean follow-up period of 34 months, although the criteria for normalization were not presented. Niranjan, et al., 13 recently reported the results of 26 cases in which the mean tumor diameter was 14.6 mm; in all 26 the mean marginal dose was 21 Gy. The tumor disappeared in six, reduced in 12, and was unchanged in five cases after 4 years. The GH hormone levels were below 1 ng/ml in eight (36.4%) and below 5 ng/ml in 14 (63.6%) cases 57 months after treatment. Ikeda, et al., 7 reported the results of 17 cases in which transsphenoidal surgery was followed by GKS. The IGF-1 level had normalized in 14 cases (82.3%) 2 years after the treatments. The authors also mentioned that pituitary function deteriorated less than after fractionated radiotherapy. Pollock, et al., 14 reported the results of treating hormone-producing adenomas in 14 cases. Hormone secretion was normal in 47% at 36 months, and the 4-year actuarial cure rate was 61%. These results are difficult to compare with each other and no simple conclusion emerges because of the variety of treatment conditions, different criteria for normalization of hormone levels, biases. Analysis of the present results, however, reveals that the goal of controlling of GH secretion has been difficult to achieve, probably due to the tumors being large and the marginal doses being smaller than in previous studies. Thus, smaller tumors treated with a higher margin dose are more likely to be cured and we recommend that tumors be less than 15 mm in diameter, 13 and that the margin dose be greater than 25 Gy. 11 The definition of normal GH levels for acromegaly has been evolving over the years. 5,6 Proposed criteria including a GH level below 1 ng/ml, 13 normal IGF-1 value according 122
5 Gamma knife surgery for GH-producing pituitary adenoma to patient age and sex, 2,7,15 or both normal GH and IGF-1, 5 although parallel hormone responses are not always seen. 2,15 Growth hormone producing adenomas have long been considered among the more difficult tumors to cure 2,6 even with the combination of microsurgery and stereotactic radiosurgery. 13,17 This has been attributed to the fact that they are already too large at the time of diagnosis for highdose radiotherapy. In addition, medications administered to control GH secretion may confer resistance to radiation effects. 10 Complications such as visceromegaly, hypertension, and diabetes mellitus often reduce quality of life 3,12 and can become life threatening. 1 Furthermore, it has been suggested by some that GH adenomas may be less radiosensitive than other pituitary adenomas. 16,17 Conclusion Gamma knife surgery was effective and safe for the control of GH-producing pituitary adenomas. Selective highdose irradiation of residual and recurrent adenomas could be administered without significant side effects. Small or microadenomas can be cured with GKS alone. Normalization of GH and IGF-1 secretion was difficult to achieve in cases in which larger tumors received low doses of radiation. Gamma knife surgery is indicated for small residual or recurrent tumors. References 1. Ayuk J, Clayton RN, Holder G, et al: Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-1 concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab 89: , Barken AL, Halasz I, Dornfeld KJ, et al: Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor 1 in patients with acromegaly. J Clin Endocrinol Metab 82: , Brada M, Rajan B, Traish D, et al: The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol 38: , Ganz JC, Backlund EO, Thorsen FA: The effects of gamma knife surgery of pituitary adenomas on tumor growth and endocrinopathies. Stereo Funct Neurosurg 61(Suppl 1):30 37, Giustina A, Barkan A, Casanueva FF, et al: Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85: , Gutt B, Hatzack C, Morrison K, et al: Conventional pituitary irradiation is effective in normalising plasma IGF-1 in patients with acromegaly. Eur J Endocrinol 144: , Ikeda H, Jokura H, Yoshimoto T: Transsphenoidal surgery and adjuvant gamma knife treatment for growth hormone-secreting pituitary adenoma. J Neurosurg 95: , Kobayashi T: A strategy for treating sellar parasellar tumors based on long-term results of microsurgery and gamma knife radiosurgery, in: Kondziolka D (ed): Radiosurgery. Basel: Karger, 2004, vol 5, pp Kobayashi T, Kida Y, Mori Y: Gamma knife radiosurgery in the treatment of Cushing disease: long-term results. J Neurosurg (Suppl 5) 97: , Landolt AM, Haller D, Lomax N, et al: Octreotide may act as a radioprotective agent in acromegaly. J Clin Endocrinol Metab 85: , Landolt AM, Haller D, Lomax N, et al: Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy. J Neurosurg 88: , McCollough WM, Marcus RB, Rhoton Jr AL, et al: Long-term follow-up of radiotherapy for pituitary adenoma: the absence of late recurrence after > 4500 cgy. Int J Radiat Oncol Biol Phys 21: , Niranjan A, Szeifert GT, Kondziolka D, et al: Gamma knife radiosurgery for growth hormone-secreting pituitary adenomas, in Kondziolka D (ed): Radiosurgery. Basel: Karger, 2002, vol 4, pp Pollock BE, Nippoldt TB, Stafford SL, et al: Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas; factors associated with endocrne normalization. J Neurosurg 97: , Powell JS, Wardlaw SL, Post KD, et al: Outcome of radiotherapy for acromegaly using normalization of insulin-like growth factor I to define cure. J Clin Endocrinol Metab 85: , Salinger DJ, Brady LW, Miyamoto CT: Radiation therapy in the treatment of pituitary adenomas. Am J Clin Oncol 15: , Thoren M, Rähn T, Guo W, et al: Stereotactic radiosurgery with the cobalt-60 gamma unit in the treatment of growth hormoneproducing pituitary tumors. Neurosurgery 29: , Witt TC, Kondziolka D, Flickinger JC, et al: Gamma knife radiosurgery for pituitary tumors, in Lundsford L, Kondziolka D, Flickinger JC (eds): Gamma Knife Brain Surgery. Basel: Karger 1998, vol 14, pp Zhang N, Pan L, Wang EM, et al: Radiosurgery for growth hormone producing pituitary adenomas. J Neurosurg (Suppl 3) 93:6 9, 2000 Address reprint requests to: Tatsuya Kobayashi, M.D., Ph.D., Nagoya Radiosurgery Center, Nagoya Kyoritsu Hospital, Hokke, Nakagawa-ku, Nagoya, , Japan. kaikou.or.jp. 123
Radioterapia degli adenomi ipofisari
Radioterapia degli adenomi ipofisari G Minniti Radiation Oncology, Sant Andrea Hospital, University of Rome Sapienza, and IRCCS Neuromed, Pozzilli (IS) Roma 6-9 Novembre 14 ! Outline " Radiation techniques
More informationSomatotroph Pituitary Adenomas (Acromegaly) The Diagnostic Pathway (11-2K-234)
Somatotroph Pituitary Adenomas (Acromegaly) The Diagnostic Pathway (11-2K-234) Common presenting symptoms/clinical assessment: Pituitary adenomas are benign neoplasms of the pituitary gland. In patients
More informationGamma knife surgery in management of secretory pituitary adenoma Preliminary evaluation of role, efficacy and safety
International Journal of Clinical Medicine Research 2014; 1(2): 48-56 Published online June 10, 2014 (http://www.aascit.org/journal/ijcmr) Gamma knife surgery in management of secretory pituitary adenoma
More informationORIGINAL PAPER. Gamma knife radiosurgery of craniopharyngioma: results of 30 cases treated at Nagoya Radiosurgery Center
Nagoya J. Med. Sci. 77. 447 ~ 454, 2015 ORIGINAL PAPER Gamma knife radiosurgery of craniopharyngioma: results of 30 cases treated at Nagoya Radiosurgery Center Tatsuya Kobayashi 1, Takahiko Tsugawa 1,
More informationAbstract. Introduction
Clinical Features and Outcome of Surgery in 30 Patients with Acromegaly A. Chandna, N. Islam, A. Jabbar, L. Zuberi, N. Haque Endocrinology Section, Department of Medicine, Aga Khan University Hospital,
More informationORIGINAL PAPER USEFUL BASE PLATE TO SUPPORT THE HEAD DURING LEKSELL SKULL FRAME PLACEMENT IN GAMMA KNIFE PERFEXION RADIOSURGERY
Nagoya J. Med. Sci. 76. 27 ~ 33, 2014 ORIGINAL PAPER USEFUL BASE PLATE TO SUPPORT THE HEAD DURING LEKSELL SKULL FRAME PLACEMENT IN GAMMA KNIFE PERFEXION RADIOSURGERY HISATO NAKAZAWA 1,2, MSc; YOSHIMASA
More informationStereotactic radiosurgery for pituitary tumors
Neurosurg Focus 14 (5):Article 10, 2003, Click here to return to Table of Contents Stereotactic radiosurgery for pituitary tumors THOMAS C. WITT, M.D. Department of Neurosurgery, Indiana University Medical
More informationSurgical therapeutic strategy for giant pituitary adenomas.
Biomedical Research 2017; 28 (19): 8284-8288 ISSN 0970-938X www.biomedres.info Surgical therapeutic strategy for giant pituitary adenomas. Han-Shun Deng, Zhi-Quan Ding, Sheng-fan Zhang, Zhi-Qiang Fa, Qing-Hua
More informationTreating a Growing Problem: A Closer Look at Acromegaly. Lisa Nachtigall, MD (Moderator) Nicholas Tritos, MD, DSc Brooke Swearingen, MD
Treating a Growing Problem: A Closer Look at Acromegaly Lisa Nachtigall, MD (Moderator) Nicholas Tritos, MD, DSc Brooke Swearingen, MD Goal Address key challenges faced by physicians who treat acromegaly
More informationTREATMENT OF CUSHING S DISEASE
TREATMENT OF CUSHING S DISEASE Surgery, Radiation, Medication Peter J Snyder, MD Professor of Medicine Disclosures Novartis Research grant Pfizer Consultant Ipsen Research grant Cortendo Research grant
More informationChanging patterns of insulin-like growth factor I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly
J Neurosurg 97:287 292, 2002 Changing patterns of insulin-like growth factor I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly ANA LAURA ESPINOSA-DE-LOS-MONTEROS,
More informationAc r o m e g a ly is an endocrine disorder characterized. A systematic analysis of disease control in acromegaly treated with radiosurgery
Neurosurg Focus 29 (4):E13, 2010 A systematic analysis of disease control in acromegaly treated with radiosurgery Is a a c Ya n g, M.D., Wo n Kim, M.D., An t o n i o De Sa l l e s, M.D., Ph.D., and Marvin
More informationThis is an author produced version of an article that appears in:
This is an author produced version of an article that appears in: CLINICAL ENDOCRINOLOGY The internet address for this paper is: https://publications.icr.ac.uk/3775/ Published text: M Brada, T V Ajithkumar,
More informationPituitary Tumors and Incidentalomas. Bijan Ahrari, MD, FACE, ECNU Palm Medical Group
Pituitary Tumors and Incidentalomas Bijan Ahrari, MD, FACE, ECNU Palm Medical Group Background Pituitary incidentaloma: a previously unsuspected pituitary lesion that is discovered on an imaging study
More informationAcromegaly: Management of the Patient Who Has Failed Surgery
Acromegaly: Management of the Patient Who Has Failed Surgery Minnesota/Midwest Chapter of the American Association of Clinical Endocrinologists 8 th Annual Meeting October 14, 2017 Mark E. Molitch, M.D.
More informationBrain Tumors. Andrew J. Fabiano, MD FAANS. Associate Professor of Neurosurgery Roswell Park Cancer Institute SUNY at Buffalo School of Medicine
Brain Tumors Andrew J. Fabiano, MD FAANS Associate Professor of Neurosurgery Roswell Park Cancer Institute SUNY at Buffalo School of Medicine Brain Tumors Brain Tumor Basics Types of Tumors Cases Brain
More informationImaging pituitary gland tumors
November 2005 Imaging pituitary gland tumors Neel Varshney,, Harvard Medical School Year IV Two categories of presenting signs of a pituitary mass Functional tumors present with symptoms due to excess
More informationThe primary management of the majority of symptomatic
J Neurosurg 116:1304 1310, 2012 Cranial nerve dysfunction following Gamma Knife surgery for pituitary adenomas: long-term incidence and risk factors Clinical article Christopher P. Cifarelli, M.D., Ph.D.,
More informationLinear Accelerator Radiosurgery for Pituitary Macroadenomas. BACKGROUND. A prospective study was conducted to assess the efficacy and side
1355 Linear Accelerator Radiosurgery for Pituitary Macroadenomas A 7-Year Follow-Up Study Juergen Voges, MD 1 Martin Kocher, MD 2 Matthias Runge, MD 1 Jorg Poggenborg, MD 3 Ralph Lehrke, MD 1 Doris Lenartz,
More informationRapid Regrowth of Intracranial Clear Cell Meningioma After Craniotomy and Gamma Knife Radiosurgery
Neurol Med Chir (Tokyo) 44, 321 325, 2004 Rapid Regrowth of Intracranial Clear Cell Meningioma After Craniotomy and Gamma Knife Radiosurgery Case Report Mitsunobu IDE, Masaaki YAMAMOTO, Shinji HAGIWARA,
More informationTherapeutic Objectives. Cushing s Disease Surgical Results. Cushing s Disease Surgical Results: Macroadenomas 10/24/2015
Therapeutic Objectives Update on the Management of Lewis S. Blevins, Jr., M.D. Correct the syndrome by lowering daily cortisol secretion to normal Eradicate any tumor that might threaten the health of
More informationProcess / Evidence Class. Clinical Assessment / III
Table 2: Endocrine Author Cozzi et al (2009) 1 Study Design: Prospectively followed case series. Fourteen patients had pre-op hypocortisolism. Patient Population: Seventy-two adult patients who underwent
More informationBrain and Spine Tumors
Brain and Spine Tumors Andrew J. Fabiano, MD FAANS Associate Professor of Neurosurgery Roswell Park Cancer Institute SUNY at Buffalo School of Medicine Brain Tumors Brain Tumor Basics Types of Tumors Cases
More informationImaging The Turkish Saddle. Russell Goodman, HMS III Dr. Gillian Lieberman
Imaging The Turkish Saddle Russell Goodman, HMS III Dr. Gillian Lieberman Learning Objectives Review the anatomy of the sellar region Discuss the differential diagnosis of sellar masses Discuss typical
More informationClinical Commissioning Policy Proposition: Stereotactic radiosurgery/ radiotherapy for the treatment of pituitary adenomas [Adults]
Clinical Commissioning Policy Proposition: Stereotactic radiosurgery/ radiotherapy for the treatment of pituitary adenomas [Adults] Reference: NHS England 1603 First published: TBC Prepared by NHS England
More informationPituitary adenomas in childhood and adolescence ISABELLE L. RICHMOND, M.D., PH.D., AND CHARLES B. WILSON, M.D.
J Neurosurg 49:163-168, 1978 Pituitary adenomas in childhood and adolescence ISABELLE L. RICHMOND, M.D., PH.D., AND CHARLES B. WILSON, M.D. Department of Neurological Surgery, University of California
More informationHigh and Low GH: an update of diagnosis and management of GH disorders
High and Low GH: an update of diagnosis and management of GH disorders Georgia Chapter-AACE 2017 Laurence Katznelson, MD Professor of Medicine and Neurosurgery Associate Dean of Graduate Medical Education
More informationProlactin-Secreting Pituitary Adenomas (Prolactinomas) The Diagnostic Pathway (11-2K-234)
Prolactin-Secreting Pituitary Adenomas (Prolactinomas) The Diagnostic Pathway (11-2K-234) Common presenting symptoms/clinical assessment: Pituitary adenomas are benign neoplasms of the pituitary gland.
More informationImpact of Gamma Knife Radiosurgery on the neurosurgical management of skull-base lesions: The Combined Approach
Radiosurgery as part of the neurosurgical armamentarium: Educational Symposium November 24 th 2011 Impact of Gamma Knife Radiosurgery on the neurosurgical management of skull-base lesions: The Combined
More informationLONG-TERM FOLLOW-UP OF ACOUSTIC SCHWANNOMA RADIOSURGERY WITH MARGINAL TUMOR DOSES OF 12 TO 13 Gy
doi:10.1016/j.ijrobp.2007.01.001 Int. J. Radiation Oncology Biol. Phys., Vol. 68, No. 3, pp. 845 851, 2007 Copyright 2007 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/07/$ see front
More informationRESEARCH ARTICLE. Abstract. Introduction. Materials and Methods
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.13.5279 Outcomes after Linac Based SRS/FSRT for Pituitary Adenomas RESEARCH ARTICLE Outcomes for Pituitary Adenoma Patients Treated with Linac- Based Stereotactic
More informationPituitary Adenomas: Evaluation and Management. Fawn M. Wolf, MD 10/27/17
Pituitary Adenomas: Evaluation and Management Fawn M. Wolf, MD 10/27/17 Over 18,000 pituitaries examined at autopsy: -10.6% contained adenomas (1.5-27%) -Frequency similar for men and women and across
More informationConventional pituitary irradiation is effective in normalising plasma IGF-I in patients with acromegaly
European Journal of Endocrinology (2001) 144 109±116 ISSN 0804-4643 CLINICAL STUDY Conventional pituitary irradiation is effective in normalising plasma IGF-I in patients with acromegaly Bodo Gutt, Christina
More informationSerial Follow-up MR Imaging after Gamma Knife Radiosurgery for Vestibular Schwannoma
AJNR Am J Neuroradiol 21:1540 1546, September 2000 Serial Follow-up MR Imaging after Gamma Knife Radiosurgery for Vestibular Schwannoma Hiroyuki Nakamura, Hidefumi Jokura, Kou Takahashi, Nagatoshi Boku,
More informationClinical Commissioning Policy: Stereotactic radiosurgery/ radiotherapy for the treatment of pituitary adenomas (all ages)
Clinical Commissioning Policy: Stereotactic radiosurgery/ radiotherapy for the treatment of pituitary adenomas (all ages) NHS England Reference: 170044P 1 NHS England INFORMATION READER BOX Directorate
More informationPreoperative Short-term Administration of Octreotide for Facilitating Transsphenoidal Removal of Invasive
Preoperative Short-term Administration of Octreotide for Facilitating Transsphenoidal Removal of Invasive Growth Hormone-secreting Macroadenomas Eiji TACHIBANA, Kiyoshi SAITO, and Jun YOSHIDA, Nagoya University
More informationTABLES. Table 1: Imaging. Congress of Neurological Surgeons Author (Year) Description of Study Classification Process / Evidence Class
TABLES Table 1: Imaging Kremer et al (2002) 2 Study Design: Prospective followed case series. Patient Population: Fifty adult patients with NFPA Study Description: Patients underwent MRI before surgery,
More informationJMSCR Vol 05 Issue 01 Page January 2017
MEN1, AIP, PRKAR1A and CDKN1B are familial pituitary syndromes found to be associated with four different genes. Pituitary gland is situated in hypophyseal fossa which is bounded supero-laterally by dural
More informationStereotactic radiosurgery in pituitary adenomas: long-term single institution experience and role of the hypothalamic-pituitary axis
Jour. of Radiosurgery and BRT, Vol. 0, pp. 1 8 Reprints available directly from the publisher Photocopying permitted by license only 2011 Old City Publishing, Inc. Published by license under the OCP Science
More informationAcromegaly: a challenging condition to diagnose and manage. C. L. Chik, MD, PhD, FRCPC University of Alberta, Edmonton
Acromegaly: a challenging condition to diagnose and manage C. L. Chik, MD, PhD, FRCPC University of Alberta, Edmonton Acromegaly: a challenging condition to diagnose and manage? Objectives: n Know the
More informationPineal Region Tumors. Diagnosis and Treatment Options
Pineal Region Tumors. Diagnosis and Treatment Options Progress in Neurological Surgery Vol. 23 Series Editor L. Dade Lunsford Pittsburgh, Pa. Pineal Region Tumors Diagnosis and Treatment Options Volume
More informationWe have previously reported good clinical results
J Neurosurg 113:48 52, 2010 Gamma Knife surgery as sole treatment for multiple brain metastases: 2-center retrospective review of 1508 cases meeting the inclusion criteria of the JLGK0901 multi-institutional
More informationEndoscopic Endonasal Surgery for Subdiaphragmatic Type Craniopharyngiomas
Original Article doi: 10.2176/nmc.oa.2018-0028 Neurol Med Chir (Tokyo) 58, 260 265, 2018 Endoscopic Endonasal Surgery for Subdiaphragmatic Type Craniopharyngiomas Hiroshi NISHIOKA, 1,2 Yuichi NAGATA, 1
More informationENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
This is an author produced version of an article that appears in: ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA The internet address for this paper is: https://publications.icr.ac.uk/5974/ Published
More informationCase Report Successful Pregnancy in a Female with a Large Prolactinoma after Pituitary Tumor Apoplexy
Case Reports in Obstetrics and Gynecology Volume 2013, Article ID 817603, 4 pages http://dx.doi.org/10.1155/2013/817603 Case Report Successful Pregnancy in a Female with a Large Prolactinoma after Pituitary
More informationOverview of radiosurgery for benign brain tumors
Overview of radiosurgery for benign brain tumors Anuj V. Peddada, M.D. Department of Radiation Oncology Penrose Cancer Center Colorado Springs, CO Objectives Provide overview of benign brain tumors meningiomas
More informationAAPM WGSBRT NTCP Optic Apparatus (chiasm and nerve)
AAPM WGSBRT NTCP Optic Apparatus (chiasm and nerve) Michael T. Milano, MD PhD Department of Radiation Oncology University of Rochester, Rochester, NY 07/16/15 AAPM WGSBRT Optic Apparatus NTCP Issam El
More informationManaging Acromegaly: Review of Two Cases
Managing Acromegaly: Review of Two Cases INDICATION AND USAGE SIGNIFOR LAR (pasireotide) for injectable suspension is a somatostatin analog indicated for the treatment of patients with acromegaly who have
More informationCertain types of tumors, in the CNS and elsewhere,
clinical article J Neurosurg 122:798 802, 2015 Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly Lucia Schwyzer, MD, Robert M. Starke, MD, John
More informationLong term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas
Pituitary (2010) 13:223 229 DOI 10.1007/s11102-010-0221-z Long term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas Edward F. Chang Michael E. Sughrue
More informationRadiotherapy in the management of optic pathway gliomas
Turkish Journal of Cancer Vol.30/ No.1/2000 Radiotherapy in the management of optic pathway gliomas FARUK ZORLU, FERAH YILDIZ, MURAT GÜRKAYNAK, FADIL AKYOL, İ. LALE ATAHAN Department of Radiation Oncology,
More informationDosimetry, see MAGIC; Polymer gel dosimetry. Fiducial tracking, see CyberKnife radiosurgery
Subject Index Acoustic neuroma, neurofibromatosis type 2 complications 103, 105 hearing outcomes 103, 105 outcome measures 101 patient selection 105 study design 101 tumor control 101 105 treatment options
More informationA Boy with Optic Glioma
Clin Pediatr Endocrinol 1994;3(Suppl 4): 169-173 Copyright(C)1994 by The Japanese Society for Pediatric Endocrinology Taisuke Okada, Sumitaka Dohno, Yousei Shimasaki, Takashi Tomoda, Makiko Koga, Kumiko
More informationACROMEGALY OCCURRING IN A PATIENT WITH A PITUITARY ADENOMA, LYMPHOCYTIC HYPOPHYSITIS, AND A RATHKE CLEFT CYST
Case Report ACROMEGALY OCCURRING IN A PATIENT WITH A PITUITARY ADENOMA, LYMPHOCYTIC HYPOPHYSITIS, AND A RATHKE CLEFT CYST Anupa Sharma, DO 1 ; Eric K.Richfield, MD, PhD 2 ; Sara E. Lubitz, MD 1 ABSTRACT
More informationReview Article Gamma Knife Radiosurgery for Acromegaly
Hindawi Publishing Corporation International Journal of Endocrinology Volume 2012, Article ID 821579, 7 pages doi:10.1155/2012/821579 Review Article Gamma Knife Radiosurgery for Acromegaly John D. Rolston
More informationCase Report Rapid Pituitary Apoplexy Regression: What Is the Time Course of Clot Resolution?
Case Reports in Radiology Volume 2015, Article ID 268974, 5 pages http://dx.doi.org/10.1155/2015/268974 Case Report Rapid Pituitary Apoplexy Regression: What Is the Time Course of Clot Resolution? Devon
More informationIMAGE-GUIDED RADIOSURGERY USING THE GAMMA KNIFE
IMAGE-GUIDED RADIOSURGERY USING THE GAMMA KNIFE L. D. LUNSFORD INTRODUCTION Image guided brain surgery became a reality in the mid-1970s after the introduction of the first methods to obtain axial imaging
More informationResults of acoustic neuroma radiosurgery: an analysis of 5 years experience using current methods
See the Letter to the Editor and the Response in this issue in Neurosurgical Forum, pp 141 142. J Neurosurg 94:1 6, 2001 Results of acoustic neuroma radiosurgery: an analysis of 5 years experience using
More informationRadiotherapy approaches to pituitary tumors
Disclosures No relevant disclosures Radiotherapy approaches to pituitary tumors Pituitary Disorders: Advances in Diagnosis and Management Steve Braunstein, MD, PhD UCSF Department of Radiation Oncology
More informationCase report. Open Access. Abstract
Open Access Case report Hyperthyroidism unmasked several years after the medical and radiosurgical treatment of an invasive macroprolactinoma inducing hypopituitarism: a case report Luca Foppiani 1 *,
More informationUW MEDICINE PATIENT EDUCATION. Acromegaly Symptoms and treatments. What is acromegaly? DRAFT. What are the symptoms? How is it diagnosed?
UW MEDICINE PATIENT EDUCATION Acromegaly Symptoms and treatments This handout explains a health condition called acromegaly. It describes tests that are used to diagnose the condition and gives basic instructions
More informationManaging Acromegaly: Biochemical Control with SIGNIFOR LAR (pasireotide)
Managing Acromegaly: Biochemical Control with SIGNIFOR LAR (pasireotide) INDICATION AND USAGE SIGNIFOR LAR (pasireotide) for injectable suspension is a somatostatin analog indicated for the treatment of
More informationThe New England Journal of Medicine LONG-TERM OUTCOMES AFTER RADIOSURGERY FOR ACOUSTIC NEUROMAS
LONG-TERM OUTCOMES AFTER RADIOSURGERY FOR ACOUSTIC NEUROMAS DOUGLAS KONDZIOLKA, M.D., L. DADE LUNSFORD, M.D., MARK R. MCLAUGHLIN, M.D., AND JOHN C. FLICKINGER, M.D. ABSTRACT Background Stereotactic radiosurgery
More information(3) Pituitary tumours
Hypopituitarism Diabetes Insipidus Pituitary tumours (2) Dr T Kemp - Endocrinology and Metabolism Unit - Steve Biko Academic Hospital (3) Pituitary tumours Pituitary microadenoma - intrasellar adenoma
More informationIntroduction to Endocrinology. Hypothalamic and Pituitary diseases Prolactinoma + Acromegaly
Introduction to Endocrinology. Hypothalamic and Pituitary diseases Prolactinoma + Acromegaly Dr. Peter Igaz MD PhD DSc 2nd Department of Medicine Semmelweis University Fields of Endocrinology Diseases
More informationPasireotide Long-Acting Repeatable (Signifor) for acromegaly first and second line
Pasireotide Long-Acting Repeatable (Signifor) for acromegaly first and second line December 2010 This technology summary is based on information available at the time of research and a limited literature
More informationCollection of Recorded Radiotherapy Seminars
IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org The Role of Radiosurgery in the Treatment of Gliomas Luis Souhami, MD Professor Department of Radiation
More informationGamma Knife Surgery for Brain Metastasis from Renal Cell Carcinoma : Relationship Between Radiological Characteristics and Initial Tumor Response
online ML Comm www.jkns.or.kr Clinical Article Jin Wook Kim, M.D. Jung Ho Han, M.D. Chul-Kee Park, M.D. Hyun-Tai Chung, Ph.D. Sun Ha Paek, M.D. Dong Gyu Kim, M.D. Department of Neurosurgery Seoul National
More informationSharon maslovitz Lis Maternity Hospital
Sharon maslovitz Lis Maternity Hospital Case report Chief complaint 27 yo, with PMC @ 31+3w, BCBA twins Complaints of severe rt parietal and retrobulbar headaches Medical background Healthy until 24yo
More informationPitfalls in early biochemical evaluation after transsphenoidal
2017, 64 (1), 1-10 Original Advance Publication doi: 10.1507/endocrj.EJ17-0261 Pitfalls in early biochemical evaluation after transsphenoidal surgery in patients with acromegaly Hiroshi Nishioka 1), 3),
More informationEvidence Based Medicine for Gamma Knife Radiosurgery. Metastatic Disease GAMMA KNIFE SURGERY
GAMMA KNIFE SURGERY Metastatic Disease Evidence Based Medicine for Gamma Knife Radiosurgery Photos courtesy of Jean Régis, Timone University Hospital, Marseille, France Brain Metastases The first report
More informationClinical Concerns about Recurrence of Non-Functioning Pituitary Adenoma
ORIGINAL ARTICLE Brain Tumor Res Treat 2016;4(1):1-7 / pissn 2288-2405 / eissn 2288-2413 http://dx.doi.org/10.14791/btrt.2016.4.1.1 Clinical Concerns about Recurrence of Non-Functioning Pituitary Adenoma
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: Original Effective Date: MM.05.008 05/12/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 03/01/2013 Section:
More informationPituitary, Parathyroid Pheochromocytomas & Paragangliomas: The 4 Ps of NETs
Pituitary, Parathyroid Pheochromocytomas & Paragangliomas: The 4 Ps of NETs Shereen Ezzat, MD, FRCP(C), FACP Professor Of Medicine & Oncology Head, Endocrine Oncology Princess Margaret Hospital/University
More informationDECISION MAKING IN AVM TREATMENT STRATEGY TREATMENT BOARD SYSTEM AT TOHOKU UNIVERSITY
Kitakanto Med. J. (S1) : 79-84, 1998 79 DECISION MAKING IN AVM TREATMENT STRATEGY TREATMENT BOARD SYSTEM AT TOHOKU UNIVERSITY Takashi Yoshimoto, Hidefumi Jokura Department of Neurosurgery, Tohoku University
More informationRepeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma
J Neurosurg 102:1004 1012, 2005 Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma RONALD J. BENVENISTE, M.D., PH.D., WESLEY A. KING, M.D., JANE WALSH, R.N., N.P., JACOB
More informationClinical Commissioning Policy: Pegvisomant for acromegaly as a third-line treatment (adults)
Clinical Commissioning Policy: Pegvisomant for acromegaly as a third-line treatment (adults) Reference: NHS England: 16050/P NHS England INFORMATION READER BOX Directorate Medical Operations and Information
More informationNANOS Patient Brochure
NANOS Patient Brochure Pituitary Tumor Copyright 2015. North American Neuro-Ophthalmology Society. All rights reserved. These brochures are produced and made available as is without warranty and for informational
More informationPegvisomant: an advance in clinical efficacy in acromegaly
European Journal of Endocrinology (2003) 148 S27 S32 ISSN 0804-4643 Pegvisomant: an advance in clinical efficacy in acromegaly Paul M Stewart The University of Birmingham, Queen Elizabeth Hospital, Edgbaston,
More informationChapter 5 Section 3.1
Radiology Chapter 5 Section 3.1 Issue Date: March 27, 1991 Authority: 32 CFR 199.4(b)(2), (b)(2)(x), (c)(2)(viii), and (g)(15) 1.0 CPT 1 PROCEDURE CODES 37243, 61793, 61795, 77261-77421, 77427-77799, 0073T
More information62-year-old woman with severe headache. Celeste Thomas November 1, 2012
62-year-old woman with severe headache Celeste Thomas November 1, 2012 History of Present Illness History of hypertension and hyperlipidemia Presented to outside hospital after awakening from sleep with
More informationEffect of skull contours on dose calculations in Gamma Knife Perfexion stereotactic radiosurgery
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 15, NUMBER 2, 2014 Effect of skull contours on dose calculations in Gamma Knife Perfexion stereotactic radiosurgery Hisato Nakazawa, 1,2a Masataka Komori,
More informationEndocrinological Outcome Among Treated Craniopharyngioma Patients
Endocrinological Outcome Among Treated Craniopharyngioma Patients Afaf Al Sagheir, MD Head & Consultant, Section of Endocrinology/Diabetes Department of Pediatrics KFSH&RC Introduction Craniopharyngiomas
More informationGamma knife radiosurgery for Koos grade 4 vestibular schwannomas
Gamma knife radiosurgery for Koos grade 4 vestibular schwannomas David Mathieu MD FRCSC, Christian Iorio-Morin MD PhD, Fahd Al Subaie MD MSc FRCSC Division of neurosurgery, Université de Sherbrooke, Centre
More informationLong-term results of treatment in patients with ACTH-secreting pituitary macroadenomas
European Journal of Endocrinology (2003) 149 195 200 ISSN 0804-4643 CLINICAL STUDY Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas S Cannavò, B Almoto, C Dall Asta
More informationAlthough histologically benign, tumors LONG-TERM RESULTS AFTER RADIOSURGERY FOR BENIGN INTRACRANIAL TUMORS CLINICAL STUDIES
CLINICAL STUDIES LONG-TERM RESULTS AFTER RADIOSURGERY FOR BENIGN INTRACRANIAL TUMORS Douglas Kondziolka, M.D. Narendra Nathoo, M.D. John C. Flickinger, M.D. Ajay Niranjan, M.Ch. Ann H. Maitz, M.S. L. Dade
More informationResearch Paper: Management of Pituitary Adenomas: Mononostril Endoscopic Transsphenoidal Surgery
Basic and Clinical March, April 2018, Volume 9, Number 2 Research Paper: Management of Pituitary Adenomas: Mononostril Endoscopic Transsphenoidal Surgery Houssein Darwish 1,2, Usamah El-Hadi 3, Georges
More informationMANAGEMENT OF HYPERGLYCEMIA IN A PATIENT WITH ACROMEGALY TREATED WITH PASIREOTIDE LAR: A CASE STUDY
Case Report MANAGEMENT OF HYPERGLYCEMIA IN A PATIENT WITH ACROMEGALY TREATED WITH PASIREOTIDE LAR: A CASE STUDY Murray B. Gordon, MD, FACE; Kellie L. Spiller, MS ABSTRACT Submitted for publication July
More informationSurgical Orthodontic Correction of Acromegaly with Mandibular Prognathism
Case Report Surgical Orthodontic Correction of Acromegaly with Mandibular Prognathism Takakaza Yagi, DDS, PhD a ; Masayoshi Kawakami, DDS, PhD b ; Kenji Takada, PhD, DDS c Abstract: A male (30 years five
More informationdoi: /j.ijrobp
doi:10.1016/j.ijrobp.2006.05.076 Int. J. Radiation Oncology Biol. Phys., Vol. 66, No. 4, Supplement, pp. S33 S39, 2006 Copyright 2006 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/06/$
More informationOutcome of Gamma Knife Radiosurgery in 82 Patients with Acromegaly: Correlation with Initial Hypersecretion
0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(8):4483 4488 Printed in U.S.A. Copyright 2005 by The Endocrine Society doi: 10.1210/jc.2005-0311 Outcome of Gamma Knife Radiosurgery
More informationTumor recurrence or regrowth in adults with nonfunctioning pituitary adenomas using GH replacement therapy
Tumor recurrence or regrowth in adults with nonfunctioning pituitary adenomas using GH replacement therapy N. C. van Varsseveld C. C. van Bunderen A. A. M. Franken H. P. F. Koppeschaar A. J. van der Lely
More informationManagement of incidental pituitary microadenomas: a cost-effectiveness analysis King J T, Justice A C, Aron D C
Management of incidental pituitary microadenomas: a cost-effectiveness analysis King J T, Justice A C, Aron D C Record Status This is a critical abstract of an economic evaluation that meets the criteria
More informationGeneral Discussion and Conclusions
16 General Discussion and Conclusions Chapter 16 254 I. Treatm ent of acrom egaly Transsphenoidal surgery Radiotherapy Pre-surgical som atostatin analog treatm ent Som atostatin analog treatm ent Current
More informationSUCCESSFUL TREATMENT OF METASTATIC BRAIN TUMOR BY CYBERKNIFE: A CASE REPORT
SUCCESSFUL TREATMENT OF METASTATIC BRAIN TUMOR BY CYBERKNIFE: A CASE REPORT Cheng-Ta Hsieh, 1 Cheng-Fu Chang, 1 Ming-Ying Liu, 1 Li-Ping Chang, 2 Dueng-Yuan Hueng, 3 Steven D. Chang, 4 and Da-Tong Ju 1
More informationResearch Article Long-Term Health-Related Quality of Life of Surgically Treated Pituitary Adenoma Patients: A Descriptive Study
International Scholarly Research Network ISRN Endocrinology Volume 202, Article ID 67530, 8 pages doi:0.5402/202/67530 Research Article Long-Term Health-Related Quality of Life of Surgically Treated Pituitary
More informationUpdate on Pediatric Brain Tumors
Update on Pediatric Brain Tumors David I. Sandberg, M.D. Director of Pediatric Neurosurgery & Associate Professor Dr. Marnie Rose Professorship in Pediatric Neurosurgery Pre-talk Questions for Audience
More informationPathology of pituitary gland. By: Shifaa Qa qa
Pathology of pituitary gland By: Shifaa Qa qa Sella turcica Adenohypophysis (80%): - epithelial cells - acidophil, basophil, chromophobe - Somatotrophs, Mammosomatotrophs, Corticotrophs, Thyrotrophs, Gonadotrophs
More informationFOR PUBLIC CONSULTATION ONLY STEREOTACTIC RADIOSURGERY/ STEROTACTIC RADIOTHERAPY FOR HAEMANGIOBLASTOMA
1 EVIDENCE SUMMARY REPORT FOR PUBLIC CONSULTATION ONLY STEREOTACTIC RADIOSURGERY/ STEROTACTIC RADIOTHERAPY FOR HAEMANGIOBLASTOMA QUESTIONS TO BE ADDRESSED: 1. What is the evidence for the clinical effectiveness
More information